These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 3046924)
1. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy. Sridaran R; Ghose M; Mahesh VB Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924 [TBL] [Abstract][Full Text] [Related]
2. Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation. Sridaran R; Mahesh VB Biol Reprod; 1989 Feb; 40(2):276-82. PubMed ID: 2655722 [TBL] [Abstract][Full Text] [Related]
3. Effects of gonadotropin-releasing hormone treatment on ovarian steroid production during midpregnancy. Sridaran R Proc Soc Exp Biol Med; 1986 May; 182(1):120-6. PubMed ID: 3515349 [TBL] [Abstract][Full Text] [Related]
4. GnRH action on luteal steroidogenesis during pregnancy. Sridaran R; Lee MA; Haynes L; Srivastava RK; Ghose M; Sridaran G; Smith CJ Steroids; 1999 Sep; 64(9):618-23. PubMed ID: 10503718 [TBL] [Abstract][Full Text] [Related]
5. Ovarian steroid production in rats treated with gonadotropin-releasing hormone during early pregnancy. Sridaran R J Steroid Biochem; 1987 Jan; 26(1):1-6. PubMed ID: 3546943 [TBL] [Abstract][Full Text] [Related]
6. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist. Smith CJ; Richards JS; Yasin K; Sangster JN; Sridaran R Biol Reprod; 1991 Feb; 44(2):382-91. PubMed ID: 2009337 [TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat. Yang H; Bhat GK; Wadley R; Wright KL; Chung BM; Whittaker JA; Dharmarajan AM; Sridaran R Biol Reprod; 2003 Jun; 68(6):2222-31. PubMed ID: 12606359 [TBL] [Abstract][Full Text] [Related]
8. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome. Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536 [TBL] [Abstract][Full Text] [Related]
9. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy. Sridaran R; Philip GH; Li H; Culty M; Liu Z; Stocco DM; Papadopoulos V J Mol Endocrinol; 1999 Feb; 22(1):45-54. PubMed ID: 9924179 [TBL] [Abstract][Full Text] [Related]
10. Direct inhibitory effect of gonadotropin-releasing hormone upon luteal luteinizing hormone receptor and steroidogenesis in hypophysectomized rats. Jones PB; Hsueh AJ Endocrinology; 1980 Dec; 107(6):1930-6. PubMed ID: 6253282 [TBL] [Abstract][Full Text] [Related]
11. Intraovarian localization of luteinizing hormone/human chorionic gonadotropin stimulation of testosterone and estradiol synthesis in the pregnant rat. Sridaran R; Gibori G Endocrinology; 1983 May; 112(5):1770-6. PubMed ID: 6832068 [TBL] [Abstract][Full Text] [Related]
12. Replacement of progesterone restores the nocturnal surge of prolactin following suppression with a gonadotropin-releasing hormone agonist during early pregnancy in the rat. Joseph IB; Sridaran R Life Sci; 1991; 48(18):1751-6. PubMed ID: 2020258 [TBL] [Abstract][Full Text] [Related]
13. Regulation of luteal cell lipoprotein receptors, sterol contents, and steroidogenesis by estradiol in the pregnant rat. Gibori G; Chen YD; Khan I; Azhar S; Reaven GM Endocrinology; 1984 Feb; 114(2):609-17. PubMed ID: 6317362 [TBL] [Abstract][Full Text] [Related]
14. Time-related changes in canine luteal regulation: in vivo effects of LH on progesterone and prolactin during pregnancy. Onclin K; Verstegen JP; Concannon PW J Reprod Fertil; 2000 Mar; 118(2):417-24. PubMed ID: 10864807 [TBL] [Abstract][Full Text] [Related]
15. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro. Bramley TA; Stirling D; Menzies GS; Baird DT Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899 [TBL] [Abstract][Full Text] [Related]
16. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase. Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the estradiol-induced luteinizing hormone surge by progesterone or antiestrogens: effects on pituitary gonadotropin-releasing hormone receptors. Attardi B; Happe HK Endocrinology; 1986 Jul; 119(1):274-83. PubMed ID: 3013589 [TBL] [Abstract][Full Text] [Related]
18. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285 [TBL] [Abstract][Full Text] [Related]